Rebalix
Amundi · sheet of 5 September 2026
Amundi · sheet of 5 September 2026ETF sheet · official issuer and register data
Amundi Core MSCI Emerging Markets UCITS ETF EUR Dist
AEMD · LU1737652583 · class UCITS ETF EUR Dist · EUR · domicile Luxembourg
Equity · GlobalSFDR art. 6
Index tracked: MSCI Emerging Markets Net Total Return USD Index
- TER
- 0.18%+ trans. 0.06%
- Fund size
- 1.1 bn EUR
- Tracking difference
- −0.06%3-year avg
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical
- Income
- Distributingannual
Launch 5 Feb 2018 · costs from the KID as of 2 Sept 2026 · 1,160 securities held · 9 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
This Sub-Fund is passively managed. The objective of this Sub-Fund is to track the performance of MSCI Emerging Markets Index (the "Index"), and to minimize the tracking error between the net asset value of the sub-fund and the performance of the Index. The anticipated level of the tracking error, under normal market conditions, is indicated in the prospectus of the Sub-Fund. The Index is a Total Return Index : the dividends net of tax paid by the Index constituents are included in the index return. The Index is an equity index representative of the…
Performance since series start (in euro) — base 100
17 Jan 2018 → 3 Sept 2026 · dividends reinvested where declared by the issuer
Returns in euro
| 1 year | +37.3% |
| 3 years | +71.0% |
| 5 years | +48.5% |
| 10 years | series too young |
| Since series start | +77.3% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 22.11% | 17.51% | 17.05% |
| Max drawdown | −13.49% | −17.76% | −24.48% |
| Sharpe | 1.34 | 0.77 | 0.26 |
| Sortino | 1.96 | 1.08 | 0.36 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · AEMD · LU17376525831
RebalixAEMD · LU1737652583 · sheet of 5 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +17.91% | +17.76% | +0.15% |
| 2024 | +14.52% | +14.68% | −0.16% |
| 2023 | +5.95% | +6.11% | −0.16% |
| 2022 | −14.99% | −14.85% | −0.14% |
| 2021 | +4.60% | +4.86% | −0.26% |
Distributions · per share, in EUR
Frequency: annual · last 12 months: 1.15 EUR (1.55% of NAV) · last ex-date 9 Dec 2025
| Year | Payments | Total (EUR) | Dividend yield |
|---|---|---|---|
| 2025 | 1 | 1.15 | +2.22% |
| 2024 | 1 | 1.18 | +2.56% |
| 2023 | 1 | 1.15 | +2.57% |
| 2022 | 1 | 1.43 | +2.64% |
| 2021 | 1 | 1.20 | +2.27% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Holdings
Portfolio as declared by the issuer · 1 Sept 2026 · 1,160 securities · top-10 weight = 37.3%
| Top holdings | Weight |
|---|---|
| 15.1% | |
| 7.1% | |
| 5.4% | |
| 2.8% | |
| 1.9% | |
| 1.6% | |
| 0.9% | |
| 0.9% | |
| 0.8% | |
| 0.8% |
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
AEMD · Borsa Italiana (ETFplus), Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 20 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/LU1737652583
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/LU1737652583
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · AEMD · LU17376525832